SCPHARMACEUTICALS INC (SCPH): Hedge Fund Holdings & 13F Analysis (Q4 2025)

SCPHARMACEUTICALS INC (SCPH)

0 + Investors. Track Smart Money conviction in SCPH. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — SCPH

Based on 109 hedge funds · latest filing: 2025 Q3 · updated quarterly

📈

Buying streak — 3 quarters in a row

last 6Q

For 3 consecutive quarters, more hedge funds added SCPH than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

🏔️

At the ownership peak (100% of max)

100% of all-time peak

109 hedge funds hold SCPH right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.

📶

Steady growth — +17% more funds vs a year ago

fund count last 6Q

+16 new funds entered over the past year (+17% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.

🟡

Slight buying edge — 58% buying

69 buying50 selling

Last quarter: 69 funds bought or added vs 50 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

📈

More new buyers each quarter (+14 vs last Q)

new funds entering per quarter

Funds opening a new SCPH position: 15 → 11 → 23 → 37. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.

💎

Buying through price weakness — shares +11%, value -98%

Value

-98%

+11%

Last quarter: funds added +11% more shares while total portfolio value only changed -98%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.

🚀

Acceleration phase — new buyers rushing in

24 → 15 → 11 → 23 → 37 new funds/Q

New funds entering each quarter: 15 → 11 → 23 → 37. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.

3.4

out of 10

Low Exit Risk

Exit risk score 3.4/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2025 Q4)	Prior (2025 Q3)	Change
Funds Holding	0	112	-100.0%
13F Shares	0	42M	-100.0%
Total Value	$0	$371M	-100.0%
New Positions	0	38	-38
Increased Positions	0	35	-35
Closed Positions	112	22	+90
Reduced Positions	0	29	-29
Total Calls	0	6	-100.0%
Total Puts	0	2	-100.0%
PUT/CALL Ratio	0.0	0.33	Bullish

Metric

All 13F Filers (2025 Q4)

Prior (2025 Q3)

Change

Funds Holding

112

-100.0%

13F Shares

42M

-100.0%

Total Value

$371M

-100.0%

New Positions

-38

Increased Positions

-35

Closed Positions

112

+90

Reduced Positions

-29

Total Calls

-100.0%

Total Puts

-100.0%

PUT/CALL Ratio

0.0

0.33

Bullish

Institutional Holders (2026 Q1)

0 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in SCPH. Verified SEC 13F-HR filings.

FILTER:All New Added To Reduced No Change | Overweight >5%

Top 25 institutional holders of SCPH — 2025 Q4 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	Yakira Capital Management, Inc.	0.87%	438,355	$2.5M
2	ORBIMED ADVISORS LLC	0.81%	6,059,528	$34.4M
3	Tejara Capital Ltd	0.73%	245,209	$1.4M
4	DIADEMA PARTNERS LP	0.67%	462,000	$2.6M
5	Newtyn Management, LLC	0.65%	940,568	$5.3M
6	APIS CAPITAL ADVISORS, LLC	0.55%	440,000	$2.5M
7	Rangeley Capital, LLC	0.46%	93,747	$532K
8	Balanced Rock Investment Advisors LLC	0.34%	83,133	$471K
9	ALPINE ASSOCIATES MANAGEMENT INC.	0.33%	961,065	$5.4M
10	Rubric Capital Management LP	0.33%	5,101,886	$28.9M
11	GABELLI & Co INVESTMENT ADVISERS, INC.	0.28%	307,800	$1.7M
12	GLAZER CAPITAL, LLC	0.26%	1,381,691	$7.8M
13	Mint Tower Capital Management B.V.	0.22%	335,000	$1.9M
14	EQUITEC PROPRIETARY MARKETS, LLC	0.21%	160,900	$912K
15	Weiss Asset Management LP	0.20%	2,881,669	$16.3M
16	Nantahala Capital Management, LLC	0.17%	861,277	$4.9M
17	DELTEC ASSET MANAGEMENT LLC	0.14%	151,837	$861K
18	ODDO BHF ASSET MANAGEMENT SAS	0.12%	575,052	$3.3M
19	CenterBook Partners LP	0.10%	348,596	$2.0M
20	PERCEPTIVE ADVISORS LLC	0.10%	583,142	$3.3M
21	CREDIT INDUSTRIEL ET COMMERCIAL	0.08%	160,000	$907K
22	Trium Capital LLP	0.07%	32,710	$185K
23	KING LUTHER CAPITAL MANAGEMENT CORP	0.05%	2,128,391	$12.1M
24	HARVEST MANAGEMENT LLC	0.05%	20,000	$113K
25	RICE HALL JAMES & ASSOCIATES, LLC	0.03%	101,713	$577K

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — SCPHARMACEUTICALS INC (SCPH)

What does the Smart Money Trend signal show for SCPH?

Buying streak — 3 quarters in a row: For 3 consecutive quarters, more hedge funds added SCPH than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for SCPH?

Slight buying edge — 58% buying: Last quarter: 69 funds bought or added vs 50 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

SCPHARMACEUTICALS INC (SCPH)

Smart Money Signals — SCPH

Buying streak — 3 quarters in a row

At the ownership peak (100% of max)

Steady growth — +17% more funds vs a year ago

Slight buying edge — 58% buying

More new buyers each quarter (+14 vs last Q)

Buying through price weakness — shares +11%, value -98%

Acceleration phase — new buyers rushing in

Hedge Fund Ownership: SCPH

Market Analysis: SCPH

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: SCPH

Hedge Fund Positioning: SCPH

Statistics: SCPH

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q1)

Frequently Asked Questions — SCPHARMACEUTICALS INC (SCPH)

Welcome to 13Foresight!